$0.6700
-0.0566-7.79%
Last update: Oct 30, 5:05 PM
Rein Therapeutics Inc (RNTX) Stock Price, Quote, News & History
RNTXNASDAQ
Twilio Inc (NYSE: TWLO) reported strong Q1 results and raised future sales guidance above estimates, causing shares to jump 20.6% in pre-market trading. Other...
You can purchase shares of Rein Therapeutics (NASDAQ:RNTX) through any online brokerage.
Other companies in Rein Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Rein Therapeutics has a consensus price target of $6.00.
The stock price for Rein Therapeutics (NASDAQ: RNTX) is $0.67 last updated October 30, 2026 at 5:05 PM EDT.
There are no upcoming dividends for Rein Therapeutics.
Rein Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Rein Therapeutics.
Rein Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03,...
